CytoSorbents delays quarterly report to review foreign exchange accounting
CTSO•CytoSorbents delayed its Form 10-Q for the quarter ended September 30, 2026, to review accounting for non-cash foreign exchange gains and losses. The company expects to file within five calendar days of the deadline and anticipates no significant change in operating results from a year earlier.
1. Filing delay
CytoSorbents delayed its Form 10-Q filing for the quarter ended September 30, 2026, while reviewing non-cash foreign exchange gains and losses for the nine months ended that date, including their accounting treatment. The company expects to file within five calendar days of the prescribed deadline and does not anticipate a significant change in operating results from the corresponding year-earlier period.




